INSP - Company ID 0001609550
The table below shows Inspire Medical Systems, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $911.98M | $802.80M | $624.80M | $407.86M | $233.39M | $115.38M |
| Cost of revenue | $133.22M | $122.99M | $96.58M | $66.11M | $33.28M | $17.62M |
| Gross profit | $778.76M | $679.82M | $528.22M | $341.74M | $200.12M | $97.76M |
| R&D | $103.17M | $114.13M | $116.54M | $68.64M | $37.35M | $26.09M |
Inspire Medical Systems, Inc. reported annual revenue of $911.98M for fiscal year 2025. That is up 13.6% from $802.80M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $16.43M (FY 2016) to $911.98M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $624.64M |
| $529.61M |
| $451.96M |
| $320.69M |
| $202.62M |
| $127.87M |
| Operating income | $50.95M | $36.08M | -$40.27M | -$47.59M | -$39.85M | -$56.21M |
| Income tax | -$79.72M | $4.94M | $1.25M | $613.00K | $72.00K | $115.00K |
| Net income | $145.42M | $53.51M | -$21.15M | -$44.88M | -$42.04M | -$57.20M |
| EPS (diluted) | $4.89 | $1.75 | -$0.72 | -$1.60 | -$1.54 | -$2.19 |